When Linda Bennett was diagnosed with amyotrophic lateral sclerosis, or ALS, in 2007 she took some time to grieve before ...

New research from King's College London has revealed a connection between ancient viral DNA embedded in the human genome and ...

The study identified which specific HERVs are important in increasing susceptibility for neurodegenerative diseases.

The DJC first reported in 2022 on architecture firm The Miller Hull Partnership's work in Spokane with Matt's Place ...

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

Hall, founder of Beacon of Hope for ALS, aims to lift people up and help them after their diagnosis. Amyotrophic lateral ...